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Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USAIntroduction: The increased risk of end-stage kidney disease among hypertensive African Americans is
partly related to APOL1 allele variants. The initial glomerulosclerosis of hypertension-associated arterio-
nephrosclerosis consists of focal global glomerulosclerosis, but in biopsy studies, focal segmental glo-
merulosclerosis is found with progression to end-stage kidney disease, particularly in African Americans.
Methods: This is a study of arterionephrosclerosis in successfully APOL1-genotyped autopsy kidney tissue
of 159 African Americans and 135 whites aged 18 to 89 years from a general population with no clinical
renal disease.
Results: Glomerulosclerosis was nearly exclusively focal global glomerulosclerosis with 3 subjects having
focal segmental glomerulosclerosis–like lesions that were unrelated to APOL1 risk status. For both races,
in multivariable analysis, the dependent variables of arteriosclerosis and glomerulosclerosis were
signiﬁcantly related to the independent variables of older age (P < 0.001) and hypertension (P < 0.001). A
relationship between APOL1 genotype and arteriosclerosis was apparent only after 35 years of age, when,
for any level of elevated blood pressure, more severe arteriosclerosis was found in the interlobular arteries
of 14 subjects with 2 APOL1 risk alleles compared to African Americans with none (n ¼ 37, P ¼ 0.02) or 1
risk allele (n ¼ 35, P ¼ 0.02).
Discussion: With the limitation of the small number of subjects contributing to the positive results, the
ﬁndings imply that APOL1 risk alleles recessively augment small-vessel arteriosclerosis in conjunction
with age and hypertension. Focal segmental glomerulosclerosis was not a signiﬁcant ﬁnding, indicating
that in the early stages of arterionephrosclerosis, the primary pathologic inﬂuence of APOL1 genotype is
vascular rather than glomerular.
KI Reports (2016) 1, 10–23; http://dx.doi.org/10.1016/j.ekir.2016.03.002
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CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).T he risk of end-stage kidney disease (ESKD) amongAmericans with nondiabetic kidney disease is
3.5-fold greater for African Americans than for whites,
with the greatest burdens falling in the diagnostic cat-
egories of hypertension-associated nephrosclerosis,
focal segmental glomerulosclerosis (FSGS), and HIVspondence: Michael D. Hughson, Department of Pathology,
rsity of Mississippi Medical Center, 2500 North State Street,
on, Mississippi 39216-4505, USA. E-mail: mhughson@bell-
.net
ved 15 March 2016; revised 27 March 2016; accepted 28
2016; published online 8 April 2016nephropathy.1 In 2010, variants in the apolipoprotein
L1 (APOL1) gene were reported by Genovese et al.2
as being a major factor in this risk. Two APOL1 risk
variants were identiﬁed. G1 consists of 2 nonsynony-
mous amino acid substitutions, S342G and I384M,
and G2 consists of the deletion of 2 amino acid residues,
N388 and Y389.2 It is thought that the risk is largely a
recessive trait requiring the inheritance of 2 risk alleles
that can be either G1 or G2.1,3
In the United States, hypertension is the attributed
cause of 25% of ESKD for whites and 34% for African
Americans.4 There is a graded relationship between the
level of hypertension and the observed risk of ESKDKidney International Reports (2016) 1, 10–23
MD Hughson et al.: Arterionephrosclerosis and APOL1 Gene Variants CLINICAL RESEARCHthat is 3.1 for mild, 6.0 for moderate, and 11.2 for se-
vere hypertension compared to reference subjects with
optimal blood pressure. This makes high blood pres-
sure, itself, a logical causative factor of ESKD; never-
theless, fewer than 0.5% of persons with hypertension
progress to the late stages of chronic kidney disease
(CKD).5 The susceptibility for ESKD among hyperten-
sive African Americans with 2 risk alleles is estimated
at somewhere between the 4% lifetime risk for FSGS in
non–HIV-infected persons and the 50% risk with HIV
nephropathy.6 This is a wide range indicative of the
uncertain mechanisms underlying the progression of
kidney disease attributed to hypertension.1,6,7
Arterionephrosclerosis, the pathologic accompani-
ment of hypertension-associated nephrosclerosis, is
characterized by arteriosclerosis, global glomerulo-
sclerosis, and cortical ﬁbrosis with tubular atrophy and
loss.7–12 The arteriosclerosis affects 3 levels of renal
arteries. The arcuate arteries and interlobular arteries
develop varying degrees of ﬁbrous intimal thickening,
and hyaline material accumulates in the walls of
afferent arterioles. Arcuate arteries have been referred
to as close and interlobular arteries remote according to
their proximity to the aorta, and their intimal thick-
ening designated as Itc for arcuate and Itr for inter-
lobular arteries.9,13–15 Tracy et al.9,13 observed that Itc
and Itr had somewhat different relationships to age and
blood pressure, with Itc reﬂecting age-related large
artery stiffness and Itr being more closely correlated
with blood pressure. In those studies, Itc appeared to
precede hypertension and to occur before Itr, leading
to a proposal that hypertension may be not a primary
disorder but secondary to small artery disease.7–9
Nevertheless, both Itc and Itr correlate strongly with
hypertension and glomerulosclerosis,13–15 while the
associations with arteriolar hyalinization are less
certain. Hill et al.16,17 thought that arteriolar hyalini-
zation may be related to a loss of autoregulatory
vascular tone and the development of FSGS in
conjunction with glomerular hypertrophy and possible
hyperﬁltration, particularly in African Americans,
while Tracy et al.18 found an unpredictable relation-
ship to blood pressure and no relationship to race.
Arterionephrosclerosis is most commonly accompa-
nied by glomerular obsolescence that in the late stages
consists of a contracted hyalinized tuft surround by
intracapsular ﬁbrosis within a largely intact Bowman’s
capsular basement membrane. This pattern of glomer-
ulosclerosis is thought to be the result of ischemia
secondary to preglomerular arteriosclerosis and will be
hereafter referred to as focal global glomerulosclerosis
(FGGS). A contrasting pattern of glomerular loss con-
sists of FSGS that is inconsistently found in arterio-
nephrosclerosis. The late stages of FSGS result inKidney International Reports (2016) 1, 10–23glomerular solidiﬁcation in which the tuft is expanded
by increased mesangial matrix and often contains hy-
aline insudates. Bowman’s capsule basement membrane
is fragmented, and there is an absence of intracapsular
ﬁbrosis. In patients with presumed primary hyper-
tension, FSGS and glomerular solidiﬁcation are
described mainly in biopsies of patients with azotemia
or proteinuria and, when identiﬁed, tend to raise the
question of a primary glomerular disease.7,16,17
Whether the glomerulosclerosis is global or
segmental, the end result is a loss of renal function.
This loss of function was evaluated in the Mayo Clinic
biopsy series of transplant donors in which lower pre-
donation glomerular ﬁltration rate (GFR) was signiﬁ-
cantly associated with age, hypertension, and increased
FGGS.19
Recently, we reported that African Americans with
2 APOL1 risk alleles have an exaggerated glomerular
loss in the ﬁrst 38 years of adult life compared to
subjects with no risk alleles or 1 risk allele.20 In the
current study, we examine the effects of APOL1 sta-
tus, age, and hypertension on the structural features
of mild to moderate arterionephrosclerosis, and, in
particular, arteriosclerosis in the different levels of
renal arteries.
METHODS
Autopsy Cohort and Collection of Specimens
and Clinical Data
The analyzed specimens consist of right kidneys
collected at autopsy between 1998 and 2005 at the
University of Mississippi Medical Center (Jackson,
MS). Race was ascertained from a combination of
medical records, reports from next of kin, and physical
examinations. Subjects with known renal disease, with
kidneys of signiﬁcantly unequal size, and with grossly
scarred or contracted kidneys were speciﬁcally
excluded. Kidneys were included if they were grossly
normal or showed mild to moderate arterio-
nephrosclerosis. Such arterionephrosclerotic kidneys
were collected from patients with a clinical diagnosis of
diabetes but were excluded if there was microscopi-
cally a diabetic nephropathy. Clinical and demographic
characteristics were obtained from University of Mis-
sissippi Medical Center records. Causes of death were
documented and medical records were reviewed for a
history of hypertension. Patients were categorized as
hypertensive on the basis of clinical history of hyper-
tension, consistently elevated blood pressures ($140/
90 mm Hg), the presence of cardiomegaly, and the
severity of intrarenal arteriosclerosis as previously
described.12,14,15 Mean arterial blood pressure (MAP)
was obtained on 113 African Americans and 66 whites
and was calculated from at least 3 blood pressure11
CLINICAL RESEARCH MD Hughson et al.: Arterionephrosclerosis and APOL1 Gene Variantsdeterminations. Blood pressures from terminal admis-
sions were not used unless patients were identiﬁed as
hypertensive and blood pressures were elevated. Pa-
tients were recorded as treated for hypertension if
there was any statement of such treatment in their
medical record or medical examiner’s report. Approval
was obtained from the Institutional Review Board of
the University of Mississippi Medical Center and the
Human Research Ethics Committee of Monash Univer-
sity, Victoria, Australia, and consent provided by next
of kin.
Measurement of Glomerulosclerosis, Cortical
Fibrosis, and Arteriosclerosis
Representative kidney blocks from the upper pole and
the mid-portion of the kidney not sampled for stere-
ology were parafﬁn embedded. Sections were cut at
4 mm and stained with periodic acid–Schiff and he-
matoxylin and with picrosirius red for ﬁbrillar
collagen. Measurement of the percentage of obsolete
glomeruli and arterial intimal thickening used sections
stained with periodic acid–Schiff and hematoxylin. The
percentage of sclerotic glomeruli was estimated by
counting sclerosed and non-sclerosed glomeruli in non-
overlapping 100X microscopic ﬁelds moving from the
subcapsular surface to inner cortex, and with at least
400 glomeruli being counted per subject. The severity
of arteriosclerosis was measured as a percentage of the
thickness of the intima to the outer wall diameter at
original magniﬁcations of 200X to 400X in interlobular
arteries 90 to 250 mm in diameter and arcuate arteries
>250 mm in diameter using the linear measurement
function of Image-Pro Plus morphometric software
(Media Cybernetics, Bethesda, MD). The percentage
thickening of interlobular or remote arteries was
designated Itr and the percentage thickening of arcuate
or close arteries as Itc. Cortical ﬁbrosis was measured in
original 200X images as the percentage of cortex
staining red with the picrosirius stain using the auto-
mated Image-Pro Plus area counting function.
Measurement of Total Glomerular Number and
Glomerular Volume
Kidney tissue was sent to Monash University for
stereologic estimation of total glomerular number
(Nglom). Nglom was estimated using the physical
disector/fractionator combination as previously
described.12,21,22 In brief, perfusion-ﬁxed kidneys were
sampled to provide a systematic, uniform random
sample of tissue blocks. These blocks were embedded
in glycolmethacrylate and then sectioned at 20 mm.
Every tenth and eleventh sections (a section pair) were
then stained with the periodic acid–Schiff stain, and
glomeruli in identical ﬁelds in each section pair were12counted using the disector principle. Stereologic point
counting at the same time on the same sampled ﬁelds
allowed the calculation of glomerular volume (Vglom).
Genetic Analysis
DNA was isolated from formalin-ﬁxed, parafﬁn-
embedded tissue as previously described.23 APOL1 risk
alleles were genotyped using TaqMan assays (ABI,
Foster City, CA). The APOL1 G1 allele was deﬁned as
the presence of the S342G variant (rs73885319A>G)
with or without the I384M (rs60910145T>G) variant,
and the G2 allele was deﬁned as the deletion of
N388Y389 (rs71785313 TTATAA/-).
Statistical Analysis
Continuous variables were tabulated using mean  SD
and discrete variables as numbers of subjects and
percents. Clinical characteristics were grouped by
race and by risk genotype status as no risk alleles, 1
risk allele, and 2 risk alleles. The microstructural
features of arterionephrosclerosis were grouped by
ages of 18 to 34 years, 35 to 54 years, and $55 years.
Analyses of data were performed with Stata/IC 10.0
(StataCorp Statistical Software, StataCorp LP, College
Station, TX) or with SigmaStat 3.5 (Systat Software
Inc., Richmond, CA).
Multiple group comparisons of continuous variables
by age or risk allele status were tested using a Kruskal–
Wallis analysis of variance on rankswithDunn’s post hoc
pairwise tests. Two-way comparisons of continuous
variables were performed by Wilcoxon rank sum tests.
Discrete variables were evaluated by c2 tests, and
2-sided Fisher’s exact tests were used to evaluate
whether genotype frequencieswere inHardy–Weinberg
equilibria. The microstructural features of glomerulo-
sclerosis, cortical ﬁbrosis, Itc, Itr, and arteriolar
hyalinization had marked positive skews with zero
values and were transformed as log10 (y þ 10). Multi-
variable analyses used fractional polynomial regressions
for untransformed data and linear regressions for trans-
formed or untransformed data when normality tests
were met or closely approximated normality. Differ-
ences in arteriosclerosis by risk genotype are tabulated
using transformed and untransformed data. Signiﬁcant
allele group differences in arteriosclerosis were evalu-
ated using recessive (2 > 0 or 1 risk alleles), dominant
(2 and 1 > 0 risk alleles), and additive (2 > 1 > 0 risk
alleles) models.
RESULTS
Clinical Characteristics and APOL1Genotypes of
the Study Cohort
This is an autopsy cohort study of 159 African Ameri-
cans and 135 whites $18 years old that had successfulKidney International Reports (2016) 1, 10–23
Table 1. Clinical and genotypic characteristics of autopsy subjects by race and APOL1 risk genotype
Characteristic
White African American P
0 risk alleles
n [ 132
0 risk alleles
n [ 61
1 risk allele
n [ 68
2 risk alleles
n [ 30 Racea AA risk genotype
Age (yr) 44.2  14.2 42.5  12.7 42.0  12.2 39.9  15.2 0.40 0.67
Male 83 (62.9%) 36 (59.0%) 37 (54.4%) 10 (33.3%) 0.90 0.38
BMI (kg/m2) 30.2  8.4 29.4  8.4 31.3  12.0 27.7  6.8 0.98 0.22
BMI $30 kg/m2 53 (40.2%) 26 (42.6%) 25 (36.7%) 6 (20%) 0.95 0.32
Hypertension 48 (35.6%) 32 (52.5%) 41 (60.3%) 14 (46.7%) 0.23 0.77
Treated hypertension 19 (14.4%) 16 (26.2%) 18 (26.5%) 6 (20.0%) 0.15 0.85
MAP (mm Hg) 102.9  13.0 108.9  16.0 108.3  17.5 107.0  16.3 0.03 0.90
CAD/CVD death 45 (32.6%) 19 (31.1%) 31 (45.6%) 10 (33.3%) 0.67 0.49
Age CAD/CVD death 53.1  13.0 49.9  10.1 41.8  9.7 42.9  6.3 0.69 0.01
Diabetes 2 (1.5%) 3 (4.9%) 4 (5.9%) 0 (0%) 1.00 DNT
AA, African American; BMI, body mass index; CAD/CVD, coronary artery disease/cerebrovascular disease; DNT, does not test; MAP, mean arterial blood pressure.
aRace is tested between whites and African Americans with no risk alleles by Wilcoxon rank sum tests for continuous variables and c2 test for discrete variables (Fisher’s exact test for
diabetes). For African Americans APOL1 risk genotype is tested by 3-way analysis of variance for continuous variables and c2 tests for discrete variables.
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that had been previously analyzed stereologically and
morphometrically. The causes of death were coronary
artery disease 33%, cerebrovascular disease 9%, pul-
monary embolus 8%, neoplastic disease 15%, chronic
lung disease 8%, accident 14%, homicide 7%, suicide
1%, and other or unknown 4%. Among African
Americans, 30 (19%) had 2 risk alleles (12, 2 G1; 13,
G1G2; and 5, 2 G2), 68 (43%) had 1 risk allele (36, G1; 32,
G2), and 61 (39%) had no risk alleles. Among whites, 3
(2%) had 1 risk allele (3, G1). The genotype distributions
in African Americans were in Hardy–Weinberg equi-
librium, and allele frequencies were similar to those in aTable 2. Microstructural kidney features and mean arterial blood pressure
White (no APOL1 risk alleles)
Group 1, 18--34 yrs Group 2, 35--54 yrs
n [ 34 P race n [ 70 P rac
MAP 99.0  13.0 0.28 103.4  11.6 0.08
Itc 5.2  5.2 0.29 11.7  6.7 0.07
Itr 2.2  3.1 0.29 6.6  6.8 0.05
Hyaline 5.1  12.1 0.63 13.0  16.6 0.91
GS 1.3  2.0 0.03 2.5  3.1 0.56
Cort ﬁb 2.4  3.0 0.70 4.1  3.6 0.26
Nglom 957,268  315,660 0.45 939,161  311,394 0.73
Vglom 5.83  1.92 0.01 7.35  2.56 0.21
African Americans (no APOL1 risk alleles)
n [ 15 n [ 33
MAP 94.3  8.9 - 110.3  14.9
Itc 3.2  2.8 - 14.5  7.3
Itr 2.0  3.9 - 9.0  7.3
Hyaline 3.1  7.1 - 11.4  12.2
GS 0.8  1.4 - 3.0  5.4
Cort ﬁb 2.3  3.0 - 5.7  5.9
Nglom 902,597  281,603 - 952,724  290,787
Vglom 8.01  2.98 - 7.99  2.39
Age categories tested by Kruskal–Wallis 1-way analysis of variance on ranks with Dunn’s post h
glomerulosclerosis (GS), and cortical fibrosis (Cort fib) are percentages of the affected structu
and percent of cortex that is fibrotic). Itc and Itr represent the intimal thickening of arcuate (Itc
MAP, mean arterial blood pressure (mm Hg); Nglom, total estimated glomerular number of righ
Kidney International Reports (2016) 1, 10–23sample of middle-aged African Americans enrolled in the
Atherosclerosis Risk in Community (ARIC) study.24 Fe-
males had a slightly, but not signiﬁcantly, higher pro-
portion of APOL1 risk alleles than expected, and more
female than male African Americans had 2 rather than
none or 1 risk alleles (P ¼ 0.02).
Table 1 summarizes the clinical and genotypic
characteristics of the autopsy subjects, comparing the
races with no risk alleles and African Americans by
risk genotype. Gender distribution, body mass index
(BMI), and rates of obesity were similar between races
and between risk genotypes. Overall, whites were
slightly older than all African Americans (P ¼ 0.04),compared by age categories and race in subjects with no risk alleles
Group 3, ‡55 yrs
P age groups
Pairwise
P < 0.05e n [ 28 P race
107.2  17.8 0.10 0.07 NS
15.9  6.3 0.02 <0.001 3>2>1
9.6  7.0 0.01 <0.001 3z2>1
9.9  11.4 0.01 0.001 3z2>1
6.1  6.6 0.01 <0.001 3>2>1
7.2  7.0 0.17 <0.001 3z2>1
908,179  339,201 0.59 0.87 NS
7.07  2.52 0.50 <0.01 2>3z1
- n [ 13 -
- 116.9  17.0 - <0.01 3z2>1
- 20.4  8.1 - <0.001 3z2>1
- 16.6  8.2 - <0.001 3>2>1
- 27.8  25.3 - <0.001 3>2z1
- 11.2  8.4 - <0.001 3>2>1
- 10.1  7.9 - <0.001 3z2>1
- 820,489  262,534 - 0.36 NS
- 7.86  3.43 - 0.74 NS
oc pairwise method. Race tested by Wilcoxon rank sum method. Arteriolar hyalinization,
res (i.e., percent of arterioles hyalinized, percent of glomeruli that are globally sclerotic,
) and interlobular (Itr) arteries as a percentage of the outer diameter of the artery wall.
t kidney; NS, not significant; Vglom, average glomerular volume (mm
3  106).
13
Table 3. African American microstructural kidney features and mean arterial blood pressure compared by age categories and risk alleles
African Americans (no APOL1 risk alleles)
Group 1, 18--34 yrs Group 2, 35--54 yrs Group 3, ‡55 yrs
P age groups PW age groupsn [ 15 P alleles n [ 33 P alleles n [ 13 P alleles
MAP 94.3  8.9 0.67 110.3  14.9 0.86 116.9  17.0 0.93 <0.01 3z2>1
Itc 3.2  2.8 0.05 14.5  7.3 0.45 20.4  8.1 0.65 <0.001 3z2>1
Itr 2.0  3.9 0.04 9.0  7.3 0.15 16.6  8.2 0.51 <0.001 3>2>1
Hyaline 3.1  7.1 0.93 11.4  12.2 0.86 27.8  25.3 0.56 <0.001 3>2z1
GS 0.8  1.4 0.50 3.0  5.4 0.18 11.2  8.4 0.51 <0.001 3>2>1
Cort ﬁb 2.3  3.0 0.97 5.7  5.9 0.69 10.1  7.9 0.80 <0.001 3z2>1
Nglom 902,597  281,603 0.25 952,724  290,787 0.59 820,489  262,534 0.29 0.36 NS
Vglom 8.01  2.98 0.21 7.99  2.39 0.23 7.86  3.43 0.18 0.74 NS
African Americans (1 APOL1 risk allele)
n [ 18 n [ 41 n [ 9
MAP 100.7  16.7 110.1  18.4 114.0  7.5 0.24 NS
Itc 6.8  5.2 14.2  7.3 21.2  8.3 <0.001 3>2>1
Itr 3.8  4.5 10.2  7.8 14.9  6.9 <0.001 3z2>1
Hyaline 6.1  11.8 12.9  15.7 20.1  22.1 0.02 3>2z1
GS 1.1  1.6 4.8  5.3 7.3  4.2 <0.001 3z2>1
Cort ﬁb 3.1  4.8 5.8  5.4 9.9  3.0 <0.001 3>2>1
Nglom 1,036,861  366,869 894,230  308,028 874,517  260,299 0.25 NS
Vglom 6.97  2.31 9.01  3.03 8.68  2.74 0.04 3z2>1
African Americans (2 APOL1 risk alleles)
n [ 12 PW alleles n [ 15 PW alleles n [ 3 PW alleles
MAP 94.5  9.9 NS 113.8  16.3 NS 116.0  7.1 NS 0.02 3z2>1
Itc 4.8  3.3 NS 16.8  8.8 NS 26.0  16.4 NS <0.001 3z2>1
Itr 0.9  1.4 NS 14.8  13.3 NS 21.6  14.5 NS <0.001 3z2>1
Hyaline 2.8  5.7 NS 14.6  18.3 NS 16.2  6.8 NS <0.01 3z2>1
GS 2.3  4.8 NS 3.9  5.6 NS 6.0  0.7 NS 0.01 3>2z1
Cort ﬁb 2.4  3.7 NS 7.3  10.3 NS 7.5  3.1 NS <0.01 3z2>1
Nglom 1,051,442  286,088 NS 871,486  254,699 NS 1,118,975  487,746a NS 0.08a NS
Vglom 6.33  2.00 NS 8.08  2.84 NS 6.29  1.62 NS 0.31 NS
Age and APOL1 risk allele categories tested by Kruskal–Wallis 1-way analysis of variance with Dunn’s post hoc pairwise method.
Cort ﬁb, cortical ﬁbrosis; GS, glomerulosclerosis; Itc, intimal thickening of arcuate arteries as a percentage of the outer diameter of the artery wall; Itr, intimal thickening of interlobular
arteries as a percentage of the outer diameter of the artery wall; MAP, mean arterial blood pressure (mm Hg); Nglom, total estimated glomerular number of right kidney; NS, not
significant; PW, pairwise comparisons, P < 0.05; Vglom, average glomerular volume (mm3  106).
aIncludes an 83-year-old woman having 2 G1 alleles and 1,678,280 glomeruli. This is greater than the 95th percentile of Nglom (1,416,713) for subjects $40 years old and could be
considered an outlier. For age #70 years, the loss of glomeruli for subjects with 2 APOL1 risk alleles is significant by linear regression (P ¼ 0.04, coefficient ¼ –9311 glomeruli per year).
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Americans had higher blood pressures than whites,
overall (P ¼ 0.02) and when comparing subjects with
no risk alleles (P ¼ 0.03). The average MAP was
normotensive for whites and hypertensive for African
Americans. Among African Americans, 11% were
classiﬁed as severely hypertensive (MAP $ 133
mm Hg) compared to 1.5% of whites. There was no
signiﬁcant difference in MAP among African Ameri-
cans by risk genotype. A similar proportion of African
Americans and whites were treated for hypertension.
The hypertensive medications consisted of b-blocking
agents, angiotensin-converting enzyme inhibitors, hy-
drochlorothiazide, calcium channel blockers, and, for 1
subject, spironolactone. Among African Americans
there were no signiﬁcant differences by risk genotype
in frequency of hypertension, treated hypertension, or
MAP.14The proportion of cardio-cerebrovascular disease
(coronary artery disease/cerebrovascular disease
[CAD/CVD]) deaths was not signiﬁcantly different
between whites and African Americans. The age of
CAD/CVD death was similar for African Americans
with 1 and 2 risk alleles, and in both groups was
signiﬁcantly younger than among African Americans
with no risk alleles (P ¼ 0.01). The difference in the age
of death from CAD/CVD is not signiﬁcantly different
between whites and African Americans with no risk
alleles (P ¼ 0.69).
Seven African Americans were diabetic. All were
male and hypertensive, and 3 died of CAD/CVD. Four
African American diabetics had 1 APOL1 risk allele, 3
no risk alleles, and none 2 APOL1 risk alleles. Two
whites were diabetic; 1 was hypertensive and dying of
CAD/CVD. Four African American diabetics and 1
white were treated for hypertension.Kidney International Reports (2016) 1, 10–23
Table 4. Multivariable analysis of microstructural features of arterionephrosclerosis and clinical characteristics
Model 1: African Americans and whites (both with no risk alleles)
Feature AA race Age (yr) Male sex BMI HTN RxHTN CAD/CVD Diabetes
Itc 1.45 0.30 0.08 0.04 5.37 0.45 2.42 0.26
–0.40 to 3.31 0.21 to 0.39 –1.68 to 1.84 –0.14 to 0.05 3.11 to 7.63 –2.13 to 3.02 0.37 to 4.47 –5.02 to 5.53
0.12 <0.001 0.93 0.40 <0.001 0.73 0.02 0.92
Itr 2.54 3.69 1.00 –0.06 4.91 –0.15 3.24 –2.79
0.67 to 4.43 1.99 to 5.39 –0.77 to 2.79 –0.17 to 0.05 2.63 to 7.19 –2.78 to 2.48 1.14 to 5.35 –8.13 to 2.54
0.01 <0.001 0.26 0.26 <0.001 0.91 0.01 0.30
Hyaline 0.29 0.08 –0.27 –0.21 12.8 –2.09 4.98 16.5
–4.10 to 4.69 –0.11 to 0.22 –4.45 to 3.90 –0.45 to 0.03 7.5 to 18.2 –8.20 to 4.01 0.14 to 9.82 4.0 to 28.9
0.89 0.51 0.90 0.09 <0.001 0.50 0.04 0.001
GS 1.36 0.03 –0.47 –0.04 2.38 –0.76 0.92 2.56
0.01 to 2.71 0.02 to 0.04 –1.75 to 0.81 –0.12 to 0.03 0.95 to 4.02 –2.14 to 1.12 –0.57 to 2.40 –1.27 to 6.38
0.048 <0.001 0.47 0.19 <0.01 0.42 0.22 0.19
Cort ﬁb 1.24 0.02 0.01 –0.01 2.91 –0.01 –0.27 3.48
–0.25 to 2.74 0.01 to 0.03 –1.40 to 1.42 –0.09 to 0.07 1.11 to 4.72 –2.09 to 2.08 –1.92 to 1.38 –0.75 to 7.72
0.10 <0.001 0.99 0.82 0.01 0.99 0.75 0.11
Model 2: African Americans
Feature APOL1 Age (yr) Male sex BMI MAP RxHTN CAD/CVD Diabetes
Itc 0.58 0.31 –1.45 --0.12 0.23 –1.46 1.07 NT
–0.91 to 2.08 0.21 to 0.41 –3.76 to 0.86 --0.23 to --0.01 0.15 to 0.32 –4.1 to 1.23 –1.4 to 3.5
0.44 <0.001 0.22 0.03 <0.001 0.39 0.39
Itr 1.44 0.27 0.95 --0.13 0.27 –2.91 1.90 NT
–0.24 to 3.12 0.16 to 0.390 –1.65 to 3.56 --0.25 to 0.007 0.18 to 0.37 –5.95 to 0.13 –1.07 to 4.5
0.09 <0.001 0.47 0.04 <0.001 0.06 0.23
Hyaline –1.12 0.10 –0.68 --0.31 0.48 –3.74 3.37 NT
–4.3 to 2.0 –0.11 to 0.31 –5.5 to 4.2 --0.53 to --0.07 0.31 to 0.66 –9.4 to 2.0 –1.9 to 8.6
0.48 0.37 0.78 0.01 <0.001 0.20 0.20
GS 0.16 0.15 –0.37 –0.04 0.11 --2.23 –0.64 NT
–0.98 to 1.3 0.07 to 0.22 –2.1 to 1.4 –0.13 to 0.04 0.04 to 0.17 --4.29 to --0.17 –2.5 to 1.2
0.78 <0.001 0.68 0.29 0.001 0.03 0.50
Cort ﬁb 0.46 0.10 –0.52 –0.09 0.19 –2.38 –2.05 NT
–0.99 to 1.91 0.004 to 0.19 –2.7 to 1.7 –0.20 to 0.01 0.11 to 0.27 –4.99 to 0.24 –4.45 to 0.35
0.53 0.04 0.65 0.09 <0.001 0.08 0.09
Correlation coefﬁcients derived from fractional polynomials of untransformed data. Within the cells, the upper values are correlation coefﬁcients with 95% conﬁdence intervals and the
lower values are P values. Significant values are in bold.
AA, African American; APOL1, genotype designated as 0, 1, and 2 risk alleles; BMI, body mass index (kg/m2); CAD/CVD, coronary artery disease/cerebrovascular disease; Cort fib,
cortical fibrosis; GS, glomerulosclerosis; HTN, hypertension; Itc, intimal thickening of arcuate arteries as a percentage of the outer diameter of the artery wall; Itr, intimal thickening of
interlobular arteries as a percentage of the outer diameter of the artery wall; MAP, mean arterial pressure (mm Hg); NT, not tested, no African Americans with diabetes and 2 risk alleles;
RxHTN, treated hypertension.
MD Hughson et al.: Arterionephrosclerosis and APOL1 Gene Variants CLINICAL RESEARCHThere were 3 African Americans who died after age
70. All were hypertensive, and all had 1 or 2 APOL1
risk alleles: a 74-year-old woman (G1,G2) with 5.4%
glomerulosclerosis, and cause of death uterine cancer; a
79-year-old man (G1) with 4.6% glomerulosclerosis and
cause of death fulminant hepatic failure; and an
83-year-old woman (G1,G1) with 6.7% glomerulo-
sclerosis and cause of death bleeding gastric ulcer.
Microstructural Characteristics and Vascular
Pathology and Relationships to Age, Race, and
Risk Genotype
The kidneys of the entire cohort ranged from normal
to having varying degrees of arterionephrosclerosis.
Three subjects with severe hypertension having
MAP $133 mm Hg (1 white with no risk alleles, 1
African American with no risk alleles, and 1 AfricanKidney International Reports (2016) 1, 10–23American with 1 risk allele) had FSGS-like lesions
involving some glomeruli but with a predominant
pattern (>50%) of FGGS. In all other kidneys, the
glomerulosclerosis was FGGS.
Table 2 compares the microanatomy and MAP of
whites and African Americans with no risk alleles by
the ages of 18 to 34 (group 1), 35 to 54 (group 2),
and $55 years old (group 3), and Table 3 compares
African Americans by risk genotype in the same age
groups. Before age 35, the structural features of arte-
rionephrosclerosis were absent or very mild, and no
racial or signiﬁcant risk genotype differences were
apparent. After 35 years of age, for both races and all 3
APOL1 risk allele categories, there was increased blood
pressure and a marked increase in all microstructural
aspects of arterionephrosclerosis that generally fol-
lowed a graded relationship with group 3 $ group 2 >15
Figure 1. Arteriolar hyalinization versus body mass index among
African Americans. Shown is an inverse relationship by polynomial
regression between the percent hyalinized arterioles and body mass
index (BMI). The 2-way relationship is not signiﬁcant (r ¼ –0.73,
P ¼ 0.21, coefficient ¼ –0.12), but the relationship becomes signif-
icant in multivariable regression with age and hypertension (age:
coefficient ¼ 0.21, P ¼ 0.04; BMI: coefficient ¼ –0.25, P ¼ 0.04;
hypertension: coefficient ¼ 11.83, P < 0.001; a ¼ 0.05:1.000).
CLINICAL RESEARCH MD Hughson et al.: Arterionephrosclerosis and APOL1 Gene Variantsgroup 1 (P # 0.001). Among subjects with no risk al-
leles, African Americans had more severe Itc, Itr, and
glomerulosclerosis than whites that became signiﬁcant
after 54 years old. Among African Americans in age
groups 2 and 3, subjects with 2 risk alleles tended to
have more severe Itc, Itr, and arteriolar hyalinization
than subjects with none or 1 risk allele, but differences
were not signiﬁcant.
There were no signiﬁcant differences in Nglom,
overall or by age categories between African Americans
and whites. With similar Nglom, African Americans had
signiﬁcantly larger Vglom than whites in the age groupsFigure 2. Intimal thickening of arcuate and interlobular arteries. (a) Arter
Linear regression showing the relationships between age and Itc (r ¼ 0.58
coefficient ¼ 0.791). The coefficients represent the percent increase in int
The slopes of the regressions are not significantly different (P ¼ 0.98). (b
Linear regression between Itc and Itr. The relationship is shifted to th
somewhat before and is more pronounced than Itr in the early developm
1618 to 34 among subjects with no risk alleles (P ¼ 0.01).
There was a trend for Vglom to increase with increasing
arterionephrosclerosis that was signiﬁcant for whites
(P < 0.01) and for African Americans with 1 risk allele
but not with none or 2 risk alleles.
Relationships Between Microstructural Charac-
teristics and Clinical Features
In multivariable analysis (Table 4), model 1 compares
African Americans and whites having no risk alleles.
The microstructural features of Itc, Itr, arteriolar hya-
linization, glomerulosclerosis, and cortical ﬁbrosis are
dependent variables, and race, age, sex, BMI, hyper-
tension, treatment of hypertension, CAD/CVD, and
diabetes are independent variables. In this model, age
and hypertension are strongly related to Itc, Itr, glo-
merulosclerosis, and cortical ﬁbrosis (all, P # 0.001).
African American race is signiﬁcantly related only to
Itr (P ¼ 0.01) and glomerulosclerosis (P < 0.05).
Arteriolar hyalinization is related to hypertension
(P < 0.001), CAD/CVD (P ¼ 0.04), and diabetes
(P ¼ 0.001) but not to race (P ¼ 0.89).
In model 2, which is applied only to African
Americans, APOL1 genotype replaces race as an in-
dependent variable, the continuous variable of MAP
is substituted for the dichotomous variable of
hypertension, and diabetes is dropped because of an
absence of diabetics among subjects with 2 risk
alleles. In this model, increased age and MAP were
signiﬁcantly associated with Itc, Itr, glomerulo-
sclerosis, and cortical ﬁbrosis (all, P # 0.001), but
APOL1 genotype was not significantly associated with
any of the features of arterionephrosclerosis and
approached signiﬁcance only for Itr (P ¼ 0.09). In modelial intimal thickening for arcuate (Itc) and interlobular (Itr) arteries.
, P < 0.001, coefficient ¼ 0.961) and age and Itr (r ¼ 0.48, P < 0.001,
imal thickening per year after 18 years old. All subjects are included.
) Intimal thickening of arcuate (Itc) versus interlobular arteries (Itr).
e right and downward along the x-axis, indicating that Itc begins
ent of arteriosclerosis.
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Figure 5. Arteriolar hyalinization versus age by APOL1 risk allele
status for African Americans. Shown are relationships by polynomial
regression between age and percent hyalinized arterioles by
APOL1 genotype (0 risk alleles, r ¼ 0.48, P < 0.001, coefficient ¼
0.64; 1 risk allele, r ¼ 0.26, P ¼ 0.04, coefficient ¼ 0.34; 2 risk alleles,
r ¼ 0.37, P ¼ 0.04, coefficient ¼ 0.36). There is no significant
difference between the alleles (0 vs. 1, P ¼ 0.89; 0 vs. 2, P ¼ 0.66;
1 vs. 2, P ¼ 0.65).
Figure 3. Arcuate artery intimal thickening (Itc) versus age by APOL1
risk allele status for African Americans. Shown are relationships by
polynomial regression between age and Itc by APOL1 genotype
(0 risk alleles, r ¼ 0.68, P < 0.001, coefficient ¼ 0.46; 1 risk allele,
r ¼ 0.68, P < 0.001, coefficient ¼ 0.45; 2 risk alleles, r ¼ 0.73,
P > 0.001, coefficient ¼ 0.51). There is no significant difference be-
tween the alleles (0 vs. 1, P ¼ 0.75; 0 vs. 2, P ¼ 0.40; 1 vs. 2, P ¼ 0.66).
MD Hughson et al.: Arterionephrosclerosis and APOL1 Gene Variants CLINICAL RESEARCH2, all of the microscopic features of arterio-
nephrosclerosis were negatively associated with treat-
ment of hypertension. The reduced glomerulosclerosis
was signiﬁcant (P ¼ 0.03), and a reduction in Itr tended
toward signiﬁcance (P ¼ 0.06). There was a curious
negative association between BMI and the severity of
arterionephrosclerosis among African Americans
(Figure 1) that was signiﬁcant for Itc (P ¼ 0.03), Itr
(p ¼ 0.04), and arteriolar hyalinization (P ¼ 0.01). This
was possibly because of a not-signiﬁcant trend towardFigure 4. Interlobular artery (Itr) intimal thickening versus age by
APOL1 risk allele status for African Americans. Shown are re-
lationships by polynomial regression between age and Itr by APOL1
genotype (0 risk alleles, r ¼ 0.55, P < 0.001, coefficient ¼ 0.36; 1 risk
allele, r ¼ 0.52, P < 0.001, coefficient ¼ 0.33; 2 risk alleles, r ¼ 0.67,
P > 0.001, coefficient ¼ 0.56). There is no significant difference
between the alleles (0 vs. 1, P ¼ 0.77; 0 vs. 2, P ¼ 0.22; 1 vs. 2,
P ¼ 0.36), but Itr for 2 risk alleles begins to separate from 0 and 1 risk
allele at about 35 years of age.
Kidney International Reports (2016) 1, 10–23earlier death among overweight and obese African
Americans but not whites (age vs. BMI: African Amer-
icans, r¼ –0.102, coefﬁcient¼ –0.167, P¼ 0.11; whites,
r ¼ 0.070, coefﬁcient 0.113, P ¼ 0.41) that suggested
that arterionephrosclerosis in African Americans may
not have had time to more fully develop.
Vascular Pathology: Relationships to Age, Blood
Pressure, and APOL1 Genotype
Increased Itc and Itr began to be seen in late adoles-
cence (Figure 2a). Under 35 years old, Itc averaged
2.3-fold Itr, with the difference diminishing to 1.3-fold
Itr at 55 years of age and older. When Itc is plotted on
the y-axis against Itr on the x-axis, the regression line
is ﬁtted down toward the x-axis and shifted slightly to
the right, indicating an earlier, more pronounced pa-
thology of Itc compared to Itr (Figure 2b). Among
African Americans, the relationships between vascular
changes and age by APOL1 genotype for Itr, Itc, and
arteriolar hyalinization are shown in Figures 3–5. Two-
way correlations between age and Itr and between age
and Itc showed a strong direct relationship for all 3 risk
genotypes (P < 0.001) with the slope of the regressions
for none, 1, and 2 APOL1 risk alleles, respectively,
being r ¼ 0.68, r ¼ 0.68, and r ¼ 0.73 for Itc; and
r ¼ 0.55, r ¼ 0.52, and r ¼ 0.67 for Itr. The differences
in the regressions between 2 and none or 1 risk allele
were not signiﬁcant for either level of blood vessel (see
ﬁgure legends). Nevertheless, the plots demonstrated a
greater elevation of Itr and to a lesser extent Itc in
subjects with 2 risk alleles beginning at about 35 years17
Table 5. Multivariable analyses of arteriosclerosis versus mean arterial blood pressure comparing race and APOL1 risk genotype
African American and white
Risk genotype Coeff. (95% CI) P Coeff. (95% CI) P
0 risk alleles Itc Itc transformed
MAP 0.34 (0.25 to 0.42) <0.001 0.007 (0.005 to 0.008) <0.001
African American –0.11 (–2.62 to 2.40) 0.93 –0.008 (–0.059 to 0.043) 0.74
0 risk alleles Itr Itr transformed
MAP 0.31 (0.23 to 0.39) <0.001 0.007 (0.005 to 0.009) <0.001
African American 0.64 (–1.75 to 3.04) 0.60 0.009 (–0.043 to 0.062) 0.71
0 risk alleles Hyaline Hyaline transformed
MAP 0.65 (0.45 to 0.84) <0.001 0.011 (0.008 to 0.014) <0.001
African American –4.37 (–10.06 to 1.31) 0.13 –0.64 (–0.151 to 0.023) 0.15
African Americans
Itc vs. MAP Itc transformed vs. MAP
0 risk alleles 0.34 (0.25 to 0.42) <0.001 0.007 (0.005 to 0.008) <0.001
1 risk allele 0.20 (0.10 to 0.30) <0.001 0.004 (0.002 to 0.006) <0.001
2 risk alleles 0.45 (0.22 to 0.69) 0.001 0.007 (0.003 to 0.011) 0.001
Itr vs. MAP Itr transformed vs. MAP
0 risk alleles 0.32 (0.24 to 0.40) <0.001 0.007 (0.004 to 0.009) <0.001
1 risk allele 0.22 (0.11 to 0.33) <0.001 0.004 (0.002 to 0.007) 0.001
2 risk alleles 0.56 (0.28 to 0.85) <0.001 0.010 (0.005 to 0.014) <0.001
Hyaline vs. MAP Hyaline transformed
0 risk alleles 0.62 (0.43 to 0.81) <0.001 0.010 (0.008 to 0.014) <0.001
1 risk allele 0.41 (0.18 to 0.64) 0.001 0.007 (0.003 to 0.012) 0.001
2 risk alleles 0.14 (0.03 to 0.24) 0.013 0.007 (0.001 to 0.012) 0.017
Correlation coefﬁcients derived from fractional polynomial regressions for untransformed and linear regression for transformed data. Number of subjects with mean arterial blood
pressure: 0 risk alleles: white, n ¼ 65; African American, n ¼ 45. 1 risk allele: African American, 46; 2 risk alleles: African American, 22.
CI, conﬁdence interval; Itc, intimal thickening of arcuate arteries as a percentage of the outer diameter of the artery wall; Itr, intimal thickening of interlobular arteries as a percentage of
the outer diameter of the artery wall; MAP, mean arterial blood pressure (mm Hg).
CLINICAL RESEARCH MD Hughson et al.: Arterionephrosclerosis and APOL1 Gene Variantsof age, but with no such separation being seen for
arteriolar hyalinization.
Table 5 shows the effects of blood pressure, race,
and APOL1 genotype on arteriosclerosis in multi-
variable analysis for all age groups. With no risk
alleles, Itc, Itr, and arteriolar hyalinization were
determined by MAP (P < 0.001) without a signiﬁcant
contribution from race. Among African Americans,
all aspects of arteriosclerosis were strongly deter-
mined by MAP for all risk genotypes (P < 0.001 for
all) with the correlation coefﬁcients indicating a more
pronounced severity of Itc and Itr for subjects with 2
APOL1 risk alleles compared to none or 1 risk allele.
Table 6 illustrates the effect of age on the relation-
ships between APOL1 risk genotype and arterio-
sclerosis among African Americans by comparing all
age groups with subjects $35 years old. When the
inﬂuence of subjects in the 18-to-34-year-old age
group who have little or no hypertension or arte-
riosclerosis are included, the differences in the ef-
fects of MAP on Itr with 2 risk alleles compared to
none or 1 risk allele approach but do not achieve
signiﬁcance (P ¼ 0.08). The differences, however,
become signiﬁcant when only subjects $35 years old
are analyzed (P ¼ 0.02).
Figure 6 demonstrates that despite similar levels of
blood pressure, African Americans $35 years old with182 APOL1 risk alleles demonstrated increased Itr for any
increase in MAP over subjects with no (P ¼ 0.02) or 1
risk allele (P ¼ 0.02). As shown in Table 7, the greater
difference in Itr was observed despite the treatment of
hypertension producing a signiﬁcant reduction in Itr
in subjects with 2 risk alleles (coefﬁcient ¼ –14.3,
P ¼ 0.04) but not in subjects with none (coefﬁcient ¼
–0.17, P ¼ 0.95) or 1 (coefﬁcient ¼ –0.81, P¼ 0.77) risk
allele. A phenotype analysis of Itr and the response of
Itr to blood pressure (Itr/MAP) demonstrates that after
age 34, subjects with 2 risk alleles had a greater degree
of interlobular artery intimal thickening in relationship
to blood pressure than subjects with none or 1 risk
allele, with the relationship to blood pressure being
signiﬁcant (P ¼ 0.02). These are ﬁndings consistent
with a recessive rather than a dominant or additive
trait (Table 8).
DISCUSSION
This work represents a cross-sectional study of subjects
selected by autopsy from the general population of
Jackson, Mississippi. As such, it evaluates the micro-
structural kidney changes in adult subjects among
whom whites serve as age-, gender-, and BMI-matched
case controls for African Americans with no risk alleles,
and African Americans with no risk alleles serve as case
controls for those with 1 or 2 risk alleles. The collectionKidney International Reports (2016) 1, 10–23
Table 6. Multivariable analyses of arteriosclerosis versus mean arterial blood pressure among African Americans by APOL1 risk genotype and
by age
African Americans, all age groups
Risk genotype Coeff. (95% CI) P Coeff. (95% CI) P
Itc Itc transformed
MAP (mm Hg) 0.39 (0.28 to 0.51) <0.001 0.004 (0.003 to 0.007) <0.001
0 vs. 2 risk alleles 1.16 (–0.76 to 3.07) 0.23 0.02 (–0.01 to 0.05) 0.25
0 vs. 1 risk allele –0.31 (–3.04 to 2.42) 0.82 0.005 (–0.05 to 0.06) 0.82
1 vs. 2 risk alleles 2.25 (–1.43 to 5.93) 0.23 0.03 (–0.04 to 0.09) 0.45
Itr Itr transformed
MAP (mm Hg) 0.40 (0.28 to 0.52) <0.001 0.006 (0.004 to 0.008) <0.001
0 vs. 2 risk alleles 1.90 (–0.21 to 4.0) 0.08 0.03 (–0.01 to 0.07) 0.14
0 vs. 1 risk allele –0.17 (–2.93 to 2.59) 0.90 0.004 (–0.06 to 0.07) 0.88
1 vs. 2 risk alleles 3.72 (–0.51 to 7.96) 0.08 0.05 (–0.03 to 0.13) 0.23
Hyaline Hyaline transformed
MAP (mm Hg) 0.61 (0.36 to 0.85) <0.001 0.009 (0.006 to 0.014) <0.001
0 vs. 2 risk alleles –0.53 (–3.68 to 2.61) 0.73 –0.001 (–0.05 to 0.05) 0.96
0 vs. 1 risk allele –0.56 (–6.0 to 4.85) 0.84 –0.02 (0.11 to 0.08) 0.74
1 vs. 2 risk alleles –0.77 (–7.53 to 5.98) 0.82 0.01 (–0.11 to 0.12) 0.90
African Americans ‡35 years old
Itc Itc transformed
MAP (mm Hg) 0.24 (0.17 to 0.45) <0.001 0.004 (0.003 to 0.007) <0.001
0 vs. 2 risk alleles 1.73 (–0.65 to 4.1) 0.15 0.03 (–0.01 to 0.06) 0.17
0 vs. 1 risk allele –0.59 (–3.6 to 2.4) 0.70 –0.004 (–0.05 to 0.05) 0.89
1 vs. 2 risk alleles 4.26 (–0.29 to 8.8) 0.07 0.06 (–0.15 to 0.13) 0.10
Itr Itr transformed
MAP (mm Hg) 0.33 (0.17 to 0.49) <0.001 0.005 (0.003 to 0.007) <0.001
0 vs. 2 risk alleles 3.25 (0.52 to 6.0) 0.021 0.06 (0.01 to 0.10) 0.019
0 vs. 1 risk allele –0.19 (–3.5 to 3.1) 0.91 0.001 (–0.07 to 0.01) 0.99
1 vs. 2 risk alleles 6.79 (1.3 to 12.3) 0.017 0.12 (0.02 to 0.21) 0.016
Hyaline Hyaline transformed
MAP (mm Hg) 0.53 (0.34 to 0.84) <0.001 0.009 (0.006 to 0.06) <0.001
0 vs. 2 risk alleles –1.34 (–5.5 to 2.9) 0.53 –0.01 (–0.08 to 0.05) 0.66
0 vs. 1 risk allele –1.25 (–7.6 to 5.1) 0.69 –0.03 (–0.13 to 0.08) 0.58
1 vs. 2 risk alleles –1.19 (–9.9 to 7.5) 0.78 0.01 (–0.14 to 0.14) 0.94
Correlation coefﬁcients derived from fractional polynomial regressions for untransformed and linear regression for transformed data. Risk allele regressions are 2-way comparisons
between 0 and 2, 0 and 1, and 1 and 2 risk alleles. Transformed values ¼ log10 (y þ 10). Signiﬁcant values are in bold. Risk alleles: number of subjects$35 years old with MAP (n); power
of tests. 0: African American (n ¼ 37); by race, a ¼ 0.05 (Itc, Itr, hyaline, $: 0.997). 1: African American (n ¼ 35); 0 vs. 1, a ¼ 0.05 (Itc: 0.993, Itr: 0.992, hyaline: 0.999). 2: African American
(n ¼ 14); 0 vs. 2, a ¼ 0.05 (Itc: 0.993, Itr: 0.995, hyaline: 0.994). 1 vs. 2, a ¼ 0.05 (Itc: 0.963, Itr: 0.987, hyaline: 0.994).
CI, conﬁdence interval; Itc, intimal thickening of arcuate arteries as a percentage of the outer diameter of the artery wall; Itr, intimal thickening of interlobular arteries as a percentage of
the outer diameter of the artery wall; MAP, mean arterial blood pressure.
MD Hughson et al.: Arterionephrosclerosis and APOL1 Gene Variants CLINICAL RESEARCHcriteria excluded clinical renal disease including dia-
betic nephropathy. While diabetes and cancer were
underrepresented and sudden death by misadventure
overrepresented, the sample contained the high fre-
quency of CAD/CVD deaths, hypertension, and obesity
that is characteristic of the general Mississippi
population.25,26
Jackson is 1 of the 4 communities participating in
the ARIC study, which has recently published results
of a more than 20-year follow-up of age-related esti-
mated GFR (eGFR) decline among African Americans
and whites $45 years old at baseline among whom
white participants served as the reference popula-
tion.24,27 African Americans with none or 1 APOL1 risk
alleles were deﬁned as low risk and those with 2 risk
alleles as high risk. Both low- and high-risk APOL1
genotypes had higher rates of new-onset hypertensionKidney International Reports (2016) 1, 10–23and diabetes and more rapid eGFR decline than whites.
APOL1 high-risk subjects had a more rapid eGFR
decline and higher rates of ESKD despite having rates
of hypertension and diabetes similar to those of low-
risk African Americans. We recently reported that
African Americans carrying 2 APOL1 risk alleles have
an exaggerated glomerular loss during the ﬁrst 30 to 40
years of adult life compared to subjects with none or 1
risk allele.20 This corresponds to the results of the ARIC
study with glomerulosclerosis and nephron loss being
the microstructural counterpart of declining eGFR.
In the present study, we show that older age and
hypertension were associated with increased glomer-
ulosclerosis and arteriosclerosis beginning at about age
35 in both African Americans and whites. Aging
African Americans had more severe manifestations
of arterionephrosclerosis than whites that might be19
Figure 6. African Americans $35 years old. Interlobular artery
intimal thickening (transformed) versus MAP by APOL1 risk allele
status. Shown are relationships by linear regression between the
percent interlobular artery intimal thickening (Itr) transformed as
log10 (Itr þ 10) and MAP by APOL1 genotype. In multivariable
regression, there is a significant difference between the alleles (0 vs.
1, P ¼ 0.99, normality ¼ 0.72, constant variance ¼ 0.23, a ¼
0.05:0.986; 0 vs. 2, P ¼ 0.019, normality ¼ 0.24, constant variance ¼
0.58, a ¼ 0.05:0.996; 1 vs. 2, P ¼ 0.016, normality ¼ 0.65, constant
variance ¼ 0.08, a ¼ 0.05:0.982).
CLINICAL RESEARCH MD Hughson et al.: Arterionephrosclerosis and APOL1 Gene Variantsattributed to their more severe hypertension, but with
subjects with 2 APOL1 risk alleles exhibiting, in a
recessive model, a more pronounced degree of ﬁbrous
intimal thickening in the interlobular arteries for any
level of increased blood pressure. We also show that
there were no racial or APOL1 risk allele differences in
arteriosclerosis before age 35, implying that interlob-
ular artery differences were acquired and not a pre-
ceding feature of race or APOL1 risk status. It is
notable that the more pronounced intimal thickening
after age 35 was found despite antihypertensive treat-
ment having a negative effect on interlobular arteryTable 7. Multivariable analyses of Itr versus mean arterial blood pressur
Americans $35 years old
Characteristic Itr
2 risk alleles, n ¼ 14 Coeff. (95% CI)
MAP (mm Hg) 0.59 (0.16 to 1.01)
RxHTN, n ¼ 4 –14.30 (–29.0 to –0.55)
a ¼ 0.05:854
normality ¼ 0.81
1 risk allele, n ¼ 35
MAP (mm Hg) 0.21 (0.05 to 0.36)
RxHTN, n ¼ 13 –0.81 (–6.4 to 4.7)
a ¼ 0.05:791
normality ¼ 0.13
0 risk alleles, n ¼ 37
MAP (mm Hg) 0.27 (0.11 to 0.44) <
RxHTN, n ¼ 11 –0.17 (–5.6 to 5.3)
a ¼ 0.05:914
normality ¼ 0.04
Linear regressions are shown with a and normality tests. Signiﬁcant P values for treatment e
Itr, % intimal thickening of interlobular arteries; Itr transformed, log10 (Itr þ 10); MAP, mean a
20intimal thickening that was signiﬁcant for 2 risk alleles
but not none or 1 risk alleles. This suggests that
without treatment the differences might be even more
pronounced.
The data that we present on arterial intimal thick-
ening and the differences between close or arcuate ar-
teries (Itc) and remote or interlobular arteries (Itr) are
very similar to those reported by Tracy et al.13,18 in their
autopsy studies on the African American population of
New Orleans. Our ﬁndings support their concept that
the anatomic levels of renal blood vessels respond
differently to age and hypertension, and further indi-
cate a more enhanced effect of blood pressure in the
presence of 2 APOL1 risk variants. The effect of APOL1
status was found primarily in the distal, interlobular
arteries and was present but not as notably in proximal,
arcuate arteries. Arteriolar hyalinization had no rela-
tionship to APOL1 genotype, a ﬁnding congruent with
the observation by Tracy et al.18 that arteriolar hyali-
nization had little relationship to race.
The glomerulosclerosis occurring in these kidneys
was nearly entirely FGGS, with FSGS being found in
only 3 subjects, all with severe hypertension and with
only 1 of the subjects having a single APOL1 risk allele.
While the individual features of FGGS, arteriosclerosis,
and cortical ﬁbrosis correlate closely with each other, it
is not at all clear how arterionephrosclerosis advances
to ESKD. The intimal thickening of small renal arteries
might in time produce enough FGGS that GFR would
diminish to a level considered late-stage CKD. This is
suggested by Elsherbiny et al.19 in 6-month post-
operative evaluations of Mayo Clinic kidney donors.
Rather than showing a compensatory increase, the
(single-kidney) GFR of 33% of the donors was <60 ml/
min per 1.73 m2 with lower function being predicted
by FGGS in pre-donation biopsies.e and treatment of hypertension by APOL1 risk genotype in African
Itr transformed
P Coeff. (95% CI) P
0.012 0.007 (0.002 to 0.013) 0.016
0.043 –0.19 (–0.37 to 0.01) 0.041
a ¼ 0.05:832
normality ¼ 0.66
0.012 0.004 (0.001 to 0.007) 0.017
0.77 –0.033 (–0.15 to 0.08) 0.57
a ¼ 0.05:713
normality ¼ 0.42
0.01 0.005 (0.002 to 0.009) <0.01
0.95 0.007 (–0.10 to 0.12) 0.89
a ¼ 0.05:920
normality ¼ 0.31
ffect are in bold.
rterial blood pressure; RxHTN, treatment of hypertension.
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Table 8. African Americans $35 years old
Risk genotype Itr Itr/MAP
0 11.0  8.2 0.09  0.07
1 11.0  7.8 0.09  0.06
2 15.9  13.3 0.15  0.10
P, 0 vs. 1 0.88 0.80
P, 0 vs. 2 0.15 0.02
P, 1 vs. 2 0.19 0.03
Comparisons by Wilcoxon rank sum tests between APOL1 risk allotypes for Itr and Itr
divided by MAP. The Itr (% intimal thickening of interlobular arteries) phenotype as a
response to mean arterial blood pressure (MAP) is recessive, that is, risk genotype 2 >
risk genotype 0 or 1.
MD Hughson et al.: Arterionephrosclerosis and APOL1 Gene Variants CLINICAL RESEARCHNevertheless, other biopsy studies indicate that at
least part of the progression of arterionephrosclerosis to
the later stages of CKD is not simply an accrual of
FGGS.16,17,28–30 Biopsies of hypertension-associated
nephropathy from African Americans, including
those from African American Study of Kidney Disease
and Hypertension (AASK) patients, demonstrate pro-
portionately less FGGS and more FSGS and solidiﬁed
glomeruli than those from whites.28,29 More recently
Larsen et al.30 examined the effect of APOL1 variants
on biopsies of arterionephrosclerosis and found an
increased frequency of FSGS and solidiﬁed glomeruli in
subjects with 2 APOL1 risk alleles. These biopsies were
performed for reduced renal function with an average
serum creatinine of 2.9 mg/dl in AASK patients and 3.6
to 4.3 mg/dl in the APOL1 study and imply that the
structural alterations of arterionephrosclerosis might
change in the later stages of CKD.10,28–30
The possibility of fundamental differences in the
mechanisms involved in early- and late-stage
hypertension-attributed renal disease and their rela-
tionship to APOL1 status might be inferred from the
study of Lipkowitz et al.,31 who found that AASK pa-
tients with APOL1 risk variants were more likely to
have progressive disease than a control group of African
Americans and that progression was unrelated to blood
pressure control. The possible transition may be related
to a more exaggerated decompensation of renal function
in African Americans with 2 APOL1 risk alleles in which
the initiating changes are related to FGGS and are
superseded by FSGS with progressive disease.16,19,31
FGGS and FSGS appear to have different underlying
pathogenetic mechanisms that in the context of arte-
rionephrosclerosis may involve variations in glomer-
ular volume. FSGS, particularly adaptive FSGS, has
been related to larger glomerular volume and a deple-
tion of podocytes covering the expanded glomerular
capillary surfaces.32–34
The estimation of Vglom represents an average
glomerular volume for the entire kidney and provides
no information about the distribution of individual
glomerular sizes. We have analyzed individual glomer-
ular volume (IGV) in our autopsy series and have foundKidney International Reports (2016) 1, 10–23increased IGV variability in older, hypertensive subjects
that is most marked in African Americans.35 The vari-
ability is skewed toward larger size with some glomeruli
becoming very large. The skew is possibly secondary to
glomerular loss owing to FGGS and may identify a pool
of glomeruli susceptible to segmental sclerosis in the
later stages of CKD.
The current study is limited by the small number
of subjects with 2 risk alleles. The P ¼ 0.02 for Itr
leaves an approximately 2% to 3% risk for false
positive results. Nevertheless, this is the largest study
of its kind and includes detailed morphometric and
stereologic analyses that will be difﬁcult to repeat. As
an autopsy study, it is restricted to subjects selected
by death due to causes unrelated to clinical renal
disease and provides little or no indication of struc-
tural factors other than the general features of arte-
rionephrosclerosis that might indicate a risk for
ESKD. This is reﬂected by our presentation of 3
African Americans aged 74, 79, and 83 years old
whose deaths were neither vascular nor renal. One
had a single and 2 had 2 APOL1 risk alleles. All were
hypertensive and had from 4.5% to 6.7% glomer-
ulosclerosis, ﬁndings that emphasize that subjects
with APOL1 risk variants can live to old age with a
degree of arterionephrosclerosis that probably repre-
sents a continuum of normal for the elderly. In
keeping with a vascular mechanism, we demonstrate
that subjects with 2 APOL1 risk alleles died of arte-
riosclerotic cardiac and cerebrovascular diseases at an
average of 6.7 years younger than African Americans
with no risk alleles, possibly corresponding to the
greater cardiovascular death rate for risk allele vari-
ants reported by Ito et al.36
While the current ﬁndings indicate a primary role
for the vascular phenotype in the initial stages of
APOL1-associated arterionephrosclerosis, there is a
considerable gap between autopsy and biopsy studies
in renal function and structure that are important to
our understanding of the effects of aging and hyper-
tension on the kidney. Many of our concepts about
hypertensive renal disease are derived from experi-
mental models that have an inﬂammatory component
and produce glomerular injury characterized by
FSGS.37,38 The role of inﬂammation in human hyper-
tension is becoming more appreciated. APOL1 protein
may, itself, be an inﬂammatory mediator through
mechanisms involving apoptosis and autophagy with
the potential signaling pathways offering opportunities
for investigating inﬂuences on the structural attributes
of arteries and glomeruli.7,39,40
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